跳至主要内容
临床试验/NCT03621371
NCT03621371已完成不适用

Metacognitive Therapy and Intolerance of Uncertainty Therapy for Generalized Anxiety Disorder in Primary Care: Randomized Controlled Pilot Study

Karolinska Institutet2 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2018年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
64
试验地点
2
主要终点
Penn State Worry Questionnaire - Measure of Symptom Change

研究概览

简要总结

The feasibilty and preliminary comparative effectiveness of two methods of cognitive-behavioral therapy - metacognitive therapy and intolerance of uncertainty therapy - for primary care patients with generalized anxiety disorder is investigated in a pilot study using a randomized controlled design. Purpose of the study is to examine the feasibility of a full-scale randomized controlled trial. Research questions primarily concern recruitment, measurement, and adherence.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary diagnosis of generalized anxiety disorder
  • Age 18 years or above
  • Being able to understand and speak Swedish without interpreter support

排除标准

  • Psychosis, bipolar disorder, severe depressive symptoms, risk of suicid, substance use disorder, intellectual disability
  • Simultaneous psychological treatment
  • If pharmacological treatment, it needs to be stable prior to and during treatment

结局指标

主要结局

Penn State Worry Questionnaire - Measure of Symptom Change

时间窗: Change from baseline symptoms at 12 weeks

Penn State Worry Questionnaire, a self-reported symptom measure of worry. Scale ranges: 16-80 scores on a scale; higher values represent a worse outcome.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Benjamin Bohman

Dr

Karolinska Institutet

研究点 (2)

Loading locations...

相似试验